Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1973

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Dissecting hematoma of the coronary artery: a possible complication of oral

contraceptive therapy.

AUTHORS

Heefner WA

SOURCE

Journal of the American Medical Association 223(5): 550-551. January 29, 1973.

ABSTRACT

This case is believed to be the first one in which an association between oral contraceptive use and the

development of a dissecting hematoma of the coronary artery has been suggested. The 27-year-old married,

nulliparous woman had been using the sequential therapy C-Quens for approximately 3 years. The details of her

case, especially autopsy findings, are detailed. 1 earlier study had noted similarly increased acid

mucopolysaccharides in the tunica media and the tunica intima underlying arterial thrombi in young women receiving

oral contraceptives. 1 researcher had stated estrogen induces an increase in acid mucopolysaccharides in all

connective tissue, this effect apparently counteracted by progesterone. C-Quens has a relatively high estrogenic and

a relatively low progestational effect. Also, Enovid has produced in rabbits hypertrophy and hyperplasia of aortic

medial smooth muscle similar to that seen in this patient. (PubHealth.info Document ID: CONT8T 544-06)

PubHealth.info NOTE: The author(s) of this article titled, "Dissecting hematoma of the coronary artery: a possible

complication of oral contraceptive therapy.", is(are) Heefner WA. The source of this article is "Journal of the

American Medical Association 223(5): 550-551. January 29, 1973.". This article was published in 1973 in English

language(s). (PubHealth.info® Document ID: CONT8T 544-06. All rights reserved with PubHealth.info) PIN: 35544

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.